The National Lung Cancer Roundtable is committed to advancing our mission to create lung cancer survivors. We continue to support our members and partners as our nation responds to the pandemic.
Please click here to learn more about what cancer patients, their families, and caregivers need to know about COVID-19.
Who We Are
The National Lung Cancer Roundtable (NLCRT) is a consortium of public, private, and voluntary organizations that work together to fight lung cancer by engaging in the research and projects that no one organization can take on alone. It is the NLCRT’s belief that working collectively will drive progress faster than working alone.
To create lung cancer survivors
To lower the impact of lung cancer through prevention, early detection, and optimal therapy
Patient-centered, evidence-based, inclusive, diverse, proactive, visionary
NLCRT Areas of Focus
The National Lung Cancer Roundtable advances initiatives that focus on provider engagement and outreach, tobacco treatment in the context of lung cancer screening, lung cancer in women, shared decision-making about screening, implementation of screening programs, access to high quality screening, policy action, triage for appropriate diagnostic evaluation and therapy, and an end to the stigma and nihilism associated with a diagnosis of lung cancer, which pervades every aspect of this disease.
Launched in March 2017, the NLCRT currently includes more than 140 member organizations across the country, among them clinical professionals, researchers, lung cancer advocates and patients, professional societies, cancer centers, academic institutions, health plans, federal agencies, and corporate associates.